跳至主要内容
临床试验/IRCT20100524004010N24
IRCT20100524004010N24已完成未知

The effect of curcumin supplementation on lipid profile, liver enzymes, inflammatory factors and hepatic steatosis in patients with Nonalcoholic Fatty Liver Disease

Shahid Beheshti University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Age >18 years old
  • Controlled Attenuation Parameter (CAP score)>263
  • Having a history of alcohol consumption less than 10 mg per day in women and less than 20 mg per day in men
  • Absence of other acute and chronic diseases and disorders of the liver (hepatitis B, C, etc.), biliary disease, known autoimmune diseases, cancer and inherited disorders affecting liver condition (storage disease of iron, and copper. ..)
  • Absence of Hypertension, cardio - vascular diseases, lung disease and kidney disease, cirrhosis and celiac disease
  • Absence of pregnancy or lactation
  • Athletes or hospitalization
  • Not consume medications such as metformin, vitamin E and Ursodeoxycholic Acid (UDCA)
  • Not consume hepatotoxic drugs such as phenytoin, tamoxifen and lithium and corticosteroids and methotrexate
  • Not consume medications of antibiotics over a week during the study period or before entering it
  • No history of weight loss surgery in the past year the 3-month weight loss program
  • No history of hypothyroidism, Cushing's syndrome and diabetes
  • Lack of gall bladder disease

排除标准

  • 未提供

研究者

相似试验

The effect of curcumin supplementation on ... | 临床试验